Target Practice: Figuring Out Which, When, and Why to Use Systemic Therapies for Metastatic Colon Cancer

Author： Holen Kyle  

Publisher： Informa Healthcare

ISSN： 0735-7907

Source： Cancer Investigation, Vol.24, Iss.1, 2006-03, pp. : 98-105

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeted Therapies for Metastatic Esophagogastric Cancer

By Reddy Deepa  

Current Treatment Options in Oncology, Vol. 12, Iss. 1, 2011-03 ,pp. : 46-60

Springer Publishing Company

Access to resources Recommend Favorite

Health-related quality of life assessment in prospective trials of systemic cytotoxic chemotherapy for metastatic castration-resistant prostate cancer: which instrument we need?

By Colloca Giuseppe  

Medical Oncology, Vol. 28, Iss. 2, 2011-06 ,pp. : 519-527

Humana Press, Inc

Access to resources Recommend Favorite

The use of blood tumour markers in the monitoring of metastatic breast cancer unassessable for response to systemic therapy

By Cheung K.L.  

Breast Cancer Research and Treatment, Vol. 67, Iss. 3, 2001-06 ,pp. : 273-278

Springer Publishing Company

Access to resources Recommend Favorite

Fulminant abdominal gas gangrene in metastatic colon cancer

By              

Oncology Letters, Vol. 3, Iss. 2, 2012-01 ,pp. : 469-471

Spandidos Publications

Access to resources Recommend Favorite

Revisiting the role of systemic therapies in patients with metastatic melanoma to the CNS

By Papadatos-Pastos Dionysis   Januszewski Adam   Dalgleish Angus  

Expert Review of Anticancer Therapy, Vol. 13, Iss. 5, 2013-05 ,pp. : 559-567

Informa Healthcare

Access to resources Recommend Favorite